Individuals with insufficient protective anti-HBs (<10 mIU/ml) classified into 3 groups (<1 mIU/ml, 1-<3 mIU/ml, and 3–10 mIU/ml) and had received a HB booster. Anti-HBs were evaluated 6 weeks post-booster.</p
a<p>Anti-HBs level was expressed in geometric mean concentration followed by minimum and maximum val...
<p>Booster doses administered to short/long responders and duration of anti-HBs positivity.</p
<p>(A) A box indicates a median and interquartile range, and error bars denote the 10th and 90th per...
(A) Individuals were grouped based on their pre-existing anti-HBs (100 mIU/ml (dark blue). (B) Geome...
Percentage of individuals with pre-existing anti-HBs 10 mIU/ml) post-booster.</p
<p>Line at GMC. A) The anti-HBs levels in the groups were not significantly different. B) The anti-H...
<p>Each data point represents one student aged 17–23 years, born after the adoption of universal neo...
Hepatitis B antibody persistence was assessed in individuals who had previously received a vaccine b...
Whether the primary Hepatitis B vaccination confers lifelong protection is debated. The aim of the s...
KISA, Ucler/0000-0002-8131-6810WOS: 000265263900003Aim: Studies have shown that no booster dose was ...
Background. The duration of protection in children and adults (including health care workers) result...
<p>Decrease in antibody to hepatitis B surface antigen (anti-HBs) by time since vaccination, and pea...
Long-term persistence of specific antibodies after primary immunization against HBV infection has be...
Hepatitis B vaccination (three-dose series) induces long-term immunity, but it is not uncommon to fi...
INTRODUCTION: Vaccination is the main tool for preventing hepatitis B virus (HBV) infection; however...
a<p>Anti-HBs level was expressed in geometric mean concentration followed by minimum and maximum val...
<p>Booster doses administered to short/long responders and duration of anti-HBs positivity.</p
<p>(A) A box indicates a median and interquartile range, and error bars denote the 10th and 90th per...
(A) Individuals were grouped based on their pre-existing anti-HBs (100 mIU/ml (dark blue). (B) Geome...
Percentage of individuals with pre-existing anti-HBs 10 mIU/ml) post-booster.</p
<p>Line at GMC. A) The anti-HBs levels in the groups were not significantly different. B) The anti-H...
<p>Each data point represents one student aged 17–23 years, born after the adoption of universal neo...
Hepatitis B antibody persistence was assessed in individuals who had previously received a vaccine b...
Whether the primary Hepatitis B vaccination confers lifelong protection is debated. The aim of the s...
KISA, Ucler/0000-0002-8131-6810WOS: 000265263900003Aim: Studies have shown that no booster dose was ...
Background. The duration of protection in children and adults (including health care workers) result...
<p>Decrease in antibody to hepatitis B surface antigen (anti-HBs) by time since vaccination, and pea...
Long-term persistence of specific antibodies after primary immunization against HBV infection has be...
Hepatitis B vaccination (three-dose series) induces long-term immunity, but it is not uncommon to fi...
INTRODUCTION: Vaccination is the main tool for preventing hepatitis B virus (HBV) infection; however...
a<p>Anti-HBs level was expressed in geometric mean concentration followed by minimum and maximum val...
<p>Booster doses administered to short/long responders and duration of anti-HBs positivity.</p
<p>(A) A box indicates a median and interquartile range, and error bars denote the 10th and 90th per...